Inhibiting Interleukin-19 Activity Ameliorates Esophageal Squamous Cell Carcinoma Progression

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Hsing, Chung Hsi ^a,b   Kwok, Franky Antonius ^c   Cheng, Hung Chi ^c   Li, Chien Feng ^a   Chang, Ming Shi ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYCLIN B1; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 19; INTERLEUKIN 19 MONOCLONAL ANTIBODY; INTERLEUKIN 20; INTERLEUKIN RECEPTOR; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCLONAL ANTIBODY; PROTEIN KINASE B; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETROSPECTIVE STUDY; SCID MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; HUMANS; INTERLEUKINS; MALE; MICE; MICE, INBRED BALB C; MICE, SCID; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN; RETROSPECTIVE STUDIES;

EID: 84885167474     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075254     Document Type: Article

References (54)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Wu MT, Lee YC, Chen CJ, Yang PW, Lee CJ, et al. (2001) Risk of betel chewing for oesophageal cancer in Taiwan. Br J Cancer 85: 658-660.
3. Department of Health (DOH) RoCR (2007) Health Statistics.
4. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, et al. (2009) EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 45: 931-991.
5. Ries LAG EM, Kosary CL, Hankey BF, Miller BA, Clegg L,et al. (Accessed August 10, 2011) SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute Available: http://seer.cancer.gov/csr/1975_2007/.
6. Coussens LM, Werb Z, (2002) Inflammation and cancer. Nature 420: 860-867.
7. Abdel-Latif MM, Duggan S, Reynolds JV, Kelleher D, (2009) Inflammation and esophageal carcinogenesis. Curr Opin Pharmacol 9: 396-404.
8. Nicolini A, Carpi A, Rossi G, (2006) Cytokines in breast cancer. Cytokine Growth Factor Rev 17: 325-337.
9. Balkwill F, Mantovani A, (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539-545.
10. Ben-Baruch A, (2006) The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 25: 357-371.
11. Purohit A, Newman SP, Reed MJ, (2002) The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res 4: 65-69.
12. Sabbioni ME, Siegrist HP, Bacchi M, Bernhard J, Castiglione M, et al. (2000) Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment. Breast Cancer Res Treat 59: 279-287.
13. Liotta LA, Rao CN, Wewer UM, (1986) Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 55: 1037-1057.
14. Kan T, Shimada Y, Sato F, Maeda M, Kawabe A, et al. (2001) Gene expression profiling in human esophageal cancers using cDNA microarray. Biochem Biophys Res Commun 286: 792-801.
15. Luker KE, Luker GD, (2006) Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 238: 30-41.
16. Sasaki K, Natsugoe S, Ishigami S, Matsumoto M, Okumura H, et al. (2008) Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer. J Surg Oncol 97: 433-438.
17. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, et al. (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22: 929-979.
18. Langer JA, Cutrone EC, Kotenko S, (2004) The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine Growth Factor Rev 15: 33-48.
19. Fickenscher H, Hor S, Kupers H, Knappe A, Wittmann S, et al. (2002) The interleukin-10 family of cytokines. Trends Immunol 23: 89-96.
20. Commins S, Steinke JW, Borish L, (2008) The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 121: 1108-1111.
21. Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC, (2001) Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 167: 3545-3549.
22. Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, et al. (2002) Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem 277: 47517-47523.
23. Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, et al. (2000) Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 1: 442-450.
24. Hsing CH, Hsieh MY, Chen WY, Cheung So E, Cheng BC, et al. (2006) Induction of interleukin-19 and interleukin-22 after cardiac surgery with cardiopulmonary bypass. Ann Thorac Surg 81: 2196-2201.
25. Hsing CH, Chiu CJ, Chang LY, Hsu CC, Chang MS, (2008) IL-19 is involved in the pathogenesis of endotoxic shock. Shock 29: 7-15.
26. Sigmundsdottir H, Gudjonsson JE, Jonsdottir I, Ludviksson BR, Valdimarsson H, (2001) The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease. Clin Exp Immunol 126: 365-369.
27. Li HH, Lin YC, Chen PJ, Hsiao CH, Lee JY, et al. (2005) Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. Br J Dermatol 153: 591-595.
28. Romer J, Hasselager E, Norby PL, Steiniche T, Thorn Clausen J, et al. (2003) Epidermal overexpression of interleukin-19 and-20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. J Invest Dermatol 121: 1306-1311.
29. Liao SC, Cheng YC, Wang YC, Wang CW, Yang SM, et al. (2004) IL-19 induced Th2 cytokines and was up-regulated in asthma patients. J Immunol 173: 6712-6718.
30. Alanara T, Karstila K, Moilanen T, Silvennoinen O, Isomaki P, (2010) Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints. Scand J Rheumatol 39: 118-126.
31. Sakurai N, Kuroiwa T, Ikeuchi H, Hiramatsu N, Maeshima A, et al. (2008) Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation. Rheumatology (Oxford) 47: 815-820.
32. Hsing CH, Cheng HC, Hsu YH, Chan CH, Yeh CH, et al. (2012) Upregulated IL-19 in breast cancer promotes tumor progression and affects clinical outcome. Clin Cancer Res 18: 713-725.
33. Hsing CH, Li HH, Hsu YH, Ho CL, Chuang SS, et al. (2008) The distribution of interleukin-19 in healthy and neoplastic tissue. Cytokine 44: 221-228.
34. Hsing CH, Ho CL, Chang LY, Lee YL, Chuang SS, et al. (2006) Tissue microarray analysis of interleukin-20 expression. Cytokine 35: 44-52.
35. Hu CP, Hsieh HG, Chien KY, Wang PY, Wang CI, et al. (1984) Biologic properties of three newly established human esophageal carcinoma cell lines. J Natl Cancer Inst 72: 577-583.
36. Jordan WJ, Eskdale J, Boniotto M, Lennon GP, Peat J, et al. (2005) Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10. Eur J Immunol 35: 1576-1582.
37. McClelland RA, Finlay P, Walker KJ, Nicholson D, Robertson JF, et al. (1990) Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer. Cancer Res 50: 3545-3550.
38. Hsu YH, Li HH, Hsieh MY, Liu MF, Huang KY, et al. (2006) Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis. Arthritis Rheum 54: 2722-2733.
39. Hsing CH, Hsu CC, Chen WY, Chang LY, Hwang JC, et al. (2007) Expression of IL-19 correlates with Th2 cytokines in uraemic patients. Nephrol Dial Transplant 22: 2230-2238.
40. Jaiswal K, Lopez-Guzman C, Souza RF, Spechler SJ, Sarosi GA Jr, (2006) Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line. Am J Physiol Gastrointest Liver Physiol 290: G335-342.
41. Wei L, Xu Z (2010) Cross-signaling among phosphinositide-3 kinase, mitogen-activated protein kinase and sonic hedgehog pathways exists in esophageal cancer. Int J Cancer.
42. Wang JS, Wang CL, Wen JF, Wang YJ, Hu YB, et al. (2008) Lithium inhibits proliferation of human esophageal cancer cell line Eca-109 by inducing a G2/M cell cycle arrest. World J Gastroenterol 14: 3982-3989.
43. Paduch R, Walter-Croneck A, Zdzisinska B, Szuster-Ciesielska A, Kandefer-Szerszen M, (2005) Role of reactive oxygen species (ROS), metalloproteinase-2 (MMP-2) and interleukin-6 (IL-6) in direct interactions between tumour cell spheroids and endothelial cell monolayer. Cell Biol Int 29: 497-505.
44. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L, (1998) Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334 (Pt 2): 297-314.
45. Swain SL, (1991) Lymphokines and the immune response: the central role of interleukin-2. Curr Opin Immunol 3: 304-310.
46. Takahashi S, Miura N, Harada T, Wang Z, Wang X, et al. (2010) Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study. J Transl Med 8: 103.
47. Baeuerle PA, Henkel T, (1994) Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12: 141-179.
48. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, et al. (2003) EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 14Suppl 5: v61-118.
49. Li YM, Pan Y, Wei Y, Cheng X, Zhou BP, et al. (2004) Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6: 459-469.
50. Rikiishi H, Nakayama K, Nitta Y, Sakihara H, Kumagai K, (1993) [The roles of cytokine in organ-specific tumor metastasis]. Hum Cell 6: 21-28.
51. Nicolson GL, (1988) Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta 948: 175-224.
52. Nicolson GL, (1988) Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 7: 143-188.
53. Zlotnik A, (2006) Involvement of chemokine receptors in organ-specific metastasis. Contrib Microbiol 13: 191-199.
54. Nguyen DX, Bos PD, Massague J, (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9: 274-284.